Search Results 1141-1150 of 17129 for Birth Control Evolution

1. Placenta, Umbilical Cord, and Umbilical Cord Blood as a Source of Therapeutic Cells - Mayo Clinic

   Abnormal pregnancy that may include birth defects of the fetus, maternal complications with the placenta or umbilical cord anatomy, and/or any complications ...

2. A Study to Evaluate the Long-Term Safety and Effectiveness of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

   Agrees to use a medically acceptable method of contraception throughout the entire study period; Willing and able to comply with scheduled visits, treatment ...

3. Feasibility Study for a Web Based Health Coaching Program - Mayo Clinic

   This study is designed to compare an intensive lifestyle and activity coaching program ("Sessions") to usual care for diabetic patients who are sedentary. The ...

4. Differences in Blood Cell Types in Peripheral Arterial Disease and Healthy Subjects - Mayo Clinic

   Poorly controlled diabetes (HbA1c > 8%). BMI < 18 or > 35. Recent other major surgery or illness within 30 days. Use of immunosuppresive medications or ...

5. A Study to Evaluate Patient Reported Outcome Measures in Children with Eye Conditions - Mayo Clinic

   The objectives of this study are: To evaluate patient-reported quality of life and functional vision across the spectrum of pediatric eye conditions;; To assess ...

6. Ceftolozane/Tazobactam in Pediatric Patients With Nosocomial Pneumonia - Mayo Clinic

   ... birth (at least seven days postnatal) to less than 18 years of age with a diagnosis of confirmed or suspected nosocomial pneumonia (NP), including hospital ...

7. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

   Effective contraception from screening and for 36 weeks after the last dose of investigational product, including for female partners of male study subjects ...

8. A Study to Develop the Use of Ultrasound to Monitor Treatment of Crohn's Disease - Mayo Clinic

   ... management of Crohn's disease. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

9. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

   Patients requiring systemic steroids for leukemia control or white blood cell (WBC)-count lowering are excluded. Autologous hematologic stem cell transplant ...

10. Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia - Mayo Clinic

    Zidovudine is not allowed as part of the anti-HIV therapy. Patients with diabetes controlled by diet or medication are allowed on trial; controlled diabetes ...